Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs
Summary: Millions of Americans who have obesity could gain insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect.
Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion
Summary: Poseida is a public clinical-stage biopharmaceutical company which creates donor-derived CAR-T cell therapies
Most Venture Investors Want Their Startups to Go Public. Not This One.
Summary: Standard venture-capital deal terms spark unusual legal fight between investor Alcon Research and its portfolio company Aurion Biotech
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
Summary: With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability
Summary: Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded pharmacies are still making them. That’s unprecedented.
